Latest Headlines

  1. Adaptive Biotechnologies And Flatiron Health Announce Integration Of clonoSEQ®: MRD Testing Into OncoEMR® 7/1/2025
  2. Seegene Launches STAgora™, A New Platform For Infectious Disease Analytics 7/1/2025

    Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics.

  3. Diatron Launches P780, The Most Advanced Clinical Chemistry System! 7/1/2025

    Diatron—a trusted partner in developing, manufacturing and marketing hematology and clinical chemistry analyzers and associated reagents for human medical and veterinary use—has launched its new clinical chemistry analyzer, the P780.

  4. PathAI Receives FDA Clearance For AISight® Dx Platform For Primary Diagnosis 6/30/2025

    PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings.

  5. RetinalGenix Technologies Contracts With LabCorp To Support DNA/GPS Platform For Advanced Genetic And Retinal Health Screening 6/27/2025

    RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of eye and systemic diseases, has entered into an agreement with LabCorp, one of the nation’s largest laboratory services organizations, to support the rollout of the RetinalGenix DNA/RNA/GPS Pharmaco-Genetic Mapping™ platform.

  6. STEMCELL Technologies Introduces STEMprep Tissue Dissociator System To Accelerate Research Discoveries 6/27/2025

    To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes.

  7. Tareen Dermatology Receives Accreditation From The College Of American Pathologists 6/27/2025

    The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Tareen Dermatology in Roseville, Minnesota based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.

  8. Orange Biomed To Present Breakthrough Microfluidic Test For Lab-Accurate HbA1c In Minutes At Adlm 2025 6/26/2025

    Orange Biomed—the inventor of the world’s first pocket-sized, microfluidic-based A1C analysis device, dedicated to improving access and accuracy in chronic condition care—has been selected to present a poster at the ADLM 2025 Clinical Lab Expo.

  9. Major Investment From Genome Canada To Help Advance ClarityDX Prostate Adoption Across Canada 6/26/2025

    Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today significant financial support from Genome Canada and Genome Alberta through the Canadian Biotechnology Innovation and Commercialization Initiative (CBIC) to accelerate the integration of ClarityDX Prostate into the standard of care for prostate cancer screening across Canada.

  10. Sysmex Corporation Receives Health Canada License For The CN-3000™ & CN-6000™ Automated Blood Coagulation Analyzers 6/25/2025

    Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, announces that Sysmex has received Health Canada license for the automated blood coagulation analyzers CN Series: